已收盘 12-26 16:00:00 美东时间
+0.030
+0.41%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
Citigroup analyst Michael Rollins maintains IHS Holding (NYSE:IHS) with a Buy and raises the price target from $8.75 to $9.
11-25 02:41
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
11-20 10:28
花旗上调Bilibili目标价升至27美元; 摩根士丹利上调英伟达目标价升至220美元;Ardent Health、Stubhub遭多家大行下调评级>>
11-17 10:49
JP Morgan analyst Philip Cusick downgrades IHS Holding (NYSE:IHS) from Overweight to Underweight and lowers the price target from $8 to $6.
11-14 20:32
Gainers Arena Group Holdings (AMEX:AREN) shares moved upwards by 11.0% to $5.2...
11-12 20:05
IHS Holding (NYSE:IHS) raises FY2025 sales outlook from $1.700 billion-$1.730 billion to $1.720 billion-$1.750 billion vs $1.731 billion estimate.
11-12 19:23
IHS Holding (NYSE:IHS) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.10 by 340 percent. This is a 172.13 percent increase over losses of $(0.61) per share from the same
11-12 19:21
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
US stocks gain on easing fear levels, wait for spending bill vote. Dow up 550 points. SoftBank sells Nvidia stake. Sea Ltd. shares drop 8%.
11-12 15:52